CMS Should Rethink Latest Lab Cut, Revaluation Proposals, Industry Says

CMS’ plans to cut reimbursement to independent labs by 26 percent next year, largely based on a policy to cap at outpatient rates, and to perform a wholesale review and revision of physician fee schedule laboratory payments in the longer term were met with resistance by ACLA, AdvaMed and other industry stakeholders.

More from Policy & Regulation

More from Medtech Insight